A review by Murray et al (2018) highlights a potential connection between increased risk of ASD in offspring following over supplementation of folic acid and vitamin B12 in mothers
Also, in elderly diabetic patients with obesity, semaglutide therapy led to a moderate but clinically relevant reduction in BW and BMI after 3 months
On average, research shows a 5% reduction in starting body weight after 12 weeks, with continued weight loss over six months to a year
This question concerns many patients prescribed glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda) for type 2 diabetes or weight management
That is normal and settles
Underlying Cause: Conditions like pernicious anemia or gastrointestinal disorders may slow recovery if not managed alongside the deficiency